Pfizer Ends Sangamo Partnership for Hemophilia Therapy
Sangamo and Pfizer together developed the treatment, called giroctocogene fitelparvovec, and it was licensed to Pfizer. The collaboration and license agreement will terminate on April 21, and Pfizer ...
Pfizer Inc. stock outperforms competitors despite losses on the day
Shares of Pfizer Inc. PFE shed 0.75% to $26.42 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 5,906.94 and Dow Jones ...
Hosted on MSN46m
Hochul urges New Yorkers to get flu, COVID vaccination ahead of respiratory illness season
Gov. Kathy Hochul announced on Monday that the new COVID-19 vaccine for the 2024-2025 season is now available across New York ...